Search

Your search keyword '"Koenig, John R."' showing total 30 results

Search Constraints

Start Over You searched for: Author "Koenig, John R." Remove constraint Author: "Koenig, John R." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
30 results on '"Koenig, John R."'

Search Results

1. Discovery of (R)-(3-fluoropyrrolidin-1-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)quinolin-2-yl)methanone (ABBV-318) and analogs as small molecule Nav1.7/ Nav1.8 blockers for the treatment of pain

2. Discovery and SAR of 4-aminopyrrolidine-2-carboxylic acid correctors of CFTR for the treatment of cystic fibrosis

3. A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model

5. Upper Stage Engine Composite Nozzle Extensions

7. Structure–activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonists

8. Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic Fibrosis

9. Emissivity Results on High Temperature Coatings for Refractory Composite Materials

10. Development of Design Analysis Methods for C/SiC Composite Structures

11. Lightweight Ablative and Ceramic Thermal Protection System Materials for NASA Exploration Systems Vehicles

12. Thermal Protection Materials Technology for NASA's Exploration Systems Mission Directorate

13. Lightweight Nonmetallic Thermal Protection Materials Technology

14. SRB thermal curtain design support

17. Discovery of TRPV1 antagonist ABT-116

19. Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: Effects of substitution about the rigidifying ring

20. α-Methylation at benzylic fragment of N-aryl- N′-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model

21. In Vitro Structure−Activity Relationship and In Vivo Characterization of 1-(Aryl)-3-(4-(amino)benzyl)urea Transient Receptor Potential Vanilloid 1 Antagonists

24. Novel Transient Receptor Potential Vanilloid 1 Receptor Antagonists for the Treatment of Pain: Structure−Activity Relationships for Ureas with Quinoline, Isoquinoline, Quinazoline, Phthalazine, Quinoxaline, and Cinnoline Moieties

25. Adenosine kinase inhibitors: polar 7-Substitutent of pyridopyrimidine derivatives improving their locomotor selectivity

26. Lightweight Nonmetallic Thermal Protection Materials Technology.

27. Pyridopyrimidine analogues as novel adenosine kinase inhibitors

28. In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonists.

29. Alpha-methylation at benzylic fragment of N-aryl-N'-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model.

30. Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.

Catalog

Books, media, physical & digital resources